Better is Aerogen; every patient, every setting. Aerogen provides improved respiratory patient treatment across the hospital
Chronic Obstructive Pulmonary Disease (COPD) is one of the most serious lung diseases prevalent today affecting 65 million people worldwide.
From moderate chronic bronchitis to severe emphysema, COPD covers a range of debilitating lung conditions that limit airflow to the lungs.
The World Health Organisation (WHO) recognises that bronchodilator medications are crucial for symptomatic management of COPD and to effectively treat severe exacerbations of the disease. World Health Organisation COPD Fact Sheet
Aerogen’s ground breaking technology and high performance aerosol drug delivery systems, the Aerogen Solo & the Aerogen Ultra, have resulted in improved patient BORG breathlessness score and lung function¹.
Every day, millions of lives worldwide are affected by asthma. Difficulties in breathing mean serious health concerns and challenge the daily activities of sufferers with this respiratory condition. Healthcare experts realise that this global epidemic needs effective medical treatment:
Bronchodilators relax the muscle around your airways and are used to ease chest tightness. They can prepare your chest for chest physiotherapy or exercise by opening your airways.
Antibiotics are used to treat, prevent and control infection. They should be taken after bronchodilators and chest physiotherapy.
DNase is used to make sputum thinner and easier to clear. It is normally prescribed once a day.
Hypertonic sodium chloride comes in different strengths; 3%, 6% or 7%. You may also know it as Nebusal® or Mucoclear®. It draws more water into the airways and sputum in the lung.
1. Cushen B, Alsaid A, Abdulkareem A and Costello RW. A Pilot Study To Assess Bronchodilator Response During An Acute Exacerbation Of COPD Using A Vibrating Mesh Nebuliser Versus Jet Nebuliser For Bronchodilator Delivery. ITS poster presentation. 2016. 2. Dugernier J, Hesse M, Vanbever R, Depoortere V, Roeseler J, Michotte JB, Laterre PF, Jamar F and Reychler G. SPECT-CT Comparison of Lung Deposition using a System combining a Vibrating-mesh Nebulizer with a Valved Holding Chamber and a Conventional Jet Nebulizer: a Randomized Cross-over Study. Pharmaceutical research. 2017;34:290-300. 3. Dunne R, Short SA and Dailey PA. Comparison of bronchodilator administration with vibrating mesh with adapter and jet nebulizer in the emergency department AARC Open Forum Abstract. 2016. 4. Hickin S, Mac Loughlin R, Sweeney L, Tatham A and Gidwani S. Comparison of mesh nebuliser versus jet nebuliser in simulated adults with chronic obstructive pulmonary disease. Poster at the College of Emergency Medicine Clinical Excellence Conference. 2014.